Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
NCT ID: NCT01513954
Last Updated: 2012-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
450 participants
OBSERVATIONAL
2012-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome
NCT02109900
Variation of Progesterone in IVF Cycles
NCT03519776
Progesterone Levels During Ovulation and Luteal Phase
NCT05076981
Vaginal Versus Combined Use of Progesterone in Fresh IVF/ICSI Cycles
NCT05089383
Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome
NCT03105323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IVF population
Long Lupron IVF Population
No interventions assigned to this group
IUI patients
Patients undergoing IUI
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cycle Day 3 FSH between 2-12
* History of regular menstrual cycles between 24-34 days
Exclusion Criteria
* Severe male factor
* Severe obesity, BMI \> 40
* More than 20 follicles on ultrasound prior to retrieval
21 Years
37 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Watson Pharmaceuticals
INDUSTRY
Red Rock Fertility Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva D Littman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Red Rock Fertility Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Red Rock Fertility Center
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20111821
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.